Bronchial artery embolization: A gratifying life-saving procedure

Mahla, Himanshu; Kunal, Shekhar; Sharma, Sohan Kumar; Mahla, Rakesh; Jain, Anita; Sharma, Sudhanshu

doi:10.1016/j.ijtb.2020.09.019

Cited by 4 publications

(3 citation statements)

References 21 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The recurrence of hemoptysis is a prevalent phenomenon post-BAE, given that BAE primarily offers palliative and symptomatic alleviation without tackling the root cause of the ailment [ 22 , 23 ]. Recent studies have reported relapse rates ranging from 9.8 to 57.5% [ 24 ]. The timeframe for recurrence exhibits significant variability among individuals, ranging from as swiftly as 1 day to several years [ 25 ].…”

Section: Discussionmentioning

confidence: 99%

The efficacy and safety of combined therapy with endobronchial tamponade and bronchial artery embolization for massive hemoptysis

Lin,

Chen,

Cai

et al. 2024

BMC Pulm Med

View full text Add to dashboard Cite

Background Massive hemoptysis is characterized by its life-threatening nature, potentially leading to airway obstruction and asphyxia. The objective of this study was to evaluate the clinical effectiveness of combining endobronchial tamponade with bronchial artery embolization (BAE) in the treatment of massive hemoptysis. Methods Between March 2018 and March 2022, a total of 67 patients with massive hemoptysis who underwent BAE were divided into two groups: the combination group (n = 26) and the BAE group (n = 41). Technical and clinical success rates were assessed, and adverse events were monitored following the treatment. Blood gas analysis and coagulation function indicators were collected before and after the treatment, and recurrence and survival rates were recorded during the follow-up period. Results All patients achieved technical success. There were no significant differences in the clinical success rate, recurrence rates at 3 and 6 months, and mortality rates at 3 months, 6 months, and 1 year between the combination group and the BAE group. However, the hemoptysis recurrence rate at 1 year was significantly lower in the combination group compared to the BAE group (15.4% vs. 39.0%, P = 0.039). No serious adverse events were reported in either group. After treatment, the combination group showed higher levels of arterial partial pressure of oxygen (PaO2), oxygenation index (PaO2/FiO2), fibrinogen (FIB), and D-dimer (D-D) compared to the BAE group (P < 0.05). Multivariate regression analysis demonstrated a significant correlation between combined therapy and hemoptysis-free survival. Conclusion Combination therapy, compared to embolization alone, exhibits superior efficacy in improving respiratory function, correcting hypoxia, stopping bleeding, and preventing recurrence. It is considered an effective and safe treatment for massive hemoptysis.

show abstract

Section: Discussionmentioning

confidence: 99%

The efficacy and safety of combined therapy with endobronchial tamponade and bronchial artery embolization for massive hemoptysis

Lin,

Chen,

Cai

et al. 2024

BMC Pulm Med

View full text Add to dashboard Cite

show abstract

“…4,18 Transcatheter BAE was effective in the vast majority of patients with hemoptysis, which significantly improved the success rate of hemostasis and reduced mortality. 19,20 Finding a small BA with complex variation in a short time is a challenging problem for interventional physicians. At present, CTA before interventional therapy can accurately identify the responsible vessels, especially the BA and collateral circulation of abnormal origin, greatly reducing the operation time and omission of embolization.…”

Section: Discussionmentioning

confidence: 99%

Application of the 5F JL4 Catheter in Bronchial Artery Embolization With the Opening in the Inferior Wall of the Aortic Arch

Dong

Niu

2023

Vasc Endovascular Surg

View full text Add to dashboard Cite

Background We investigated the efficacy and safety of bronchial artery embolization (BAE) using a 5F JL4 catheter in patients with hemoptysis and a bronchial artery opening in the inferior wall of the aortic arch. Methods This was a single-center retrospective study. Seventeen patients underwent BAE using 5F JL4. We then evaluated technical success (TS), clinical success (CS), incidence of complications, and hemoptysis recurrence rate (RR). Results The TS rate of microcatheter superselective catheterization and CS rate after surgery were 100%, and the incidence of severe complications and postoperative RR were 17.6%. Conclusions Bronchial artery embolization for hemoptysis with a BA opening in the inferior wall of the aortic arch using the 5F JL4 catheter could be a safe method. The short- and medium-term results were excellent.

show abstract

“…Predictors of recurrent haemoptysis (Table 8 ) were as follows: recruitment of non-bronchial systemic collaterals [ 3 , 6 ], diabetes [ 8 ], presence of an aspergilloma [ 8 ], feeding vessels from internal mammary artery [ 8 ], multidrug-resistant tuberculosis, co-existent pulmonary interstitial lung disease, patients with malignant diseases [ 27 ], unstable haemodynamics and prolonged coagulation [ 9 , 42 ].…”

Section: Outcome Of Bae In Haemoptysismentioning

confidence: 99%